Spero Health Brings Relief for Addiction and Lifesaving Care to Thousands in 2022
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Jan 5, 2023--
Spero Health, a national leader who has helped more than 35,000 patients on their journey to stable recovery from addiction using an innovative evidence-based integrated care model, released a 2022 organizational summary of the impact their outpatient addiction treatment program has had on communities struggling with the drug epidemic. As part of their commitment to bringing high quality, comprehensive, affordable treatment options to more people in more places, the organization focused on expansion and enhancement of services to transform treatment options creating more avenues for people to receive care in 2022.
Spero Health offers a community-based approach to treatment, so individuals have quick access to life-saving care close to home allowing them to stay connected to their communities. In 2022 Spero Health reported more than a half-million addiction treatment visits which include a combination of: medical care provided by physicians and nurse practitioners, group and individual counseling and other recovery support assistance. Since the organizations launch 5 years ago, they have expanded to more than 95 communities in 6 states bringing needed resources to aid in the drug epidemic that has plagued the nation in recent years. “The scale of the addiction epidemic is alarming. Drug overdose is currently the leading cause of unintentional death in our country and millions more suffer from non-fatal substance misuse as drug trends continue to change with fentanyl and stimulant use a new deadly threat. Last year we opened 25 new Spero Health clinics with expansion into West Virginia and have built the framework to increase access to care to thousands of individuals in the coming years. While we celebrate the progress made in the lives changed through recovery, we know that there is much work to be done to combat this epidemic especially as new drug threats immerge. Our treatment program continues to evolve as our patients needs change,” said Spero Health’s CEO Steve Priest.
Focusing on enhanced clinical services in 2022, Spero Health expanded treatment for Hepatitis C in all locations, increased peer support services, Intensive Outpatient Programs (IOP), and telehealth services with the launch of a new virtual care platform. Spero Health treatment teams incorporated new protocols to address the rise in fentanyl and stimulant use as well as completed comprehensive training on refined clinical and operational processes to improve patient engagement. Looking at patient outcomes, the organization partnered with technology companies to provide digital tools for clinical monitoring to evaluate patients progress in recovery. “Spero Health continues to find innovative ways with new technologies to equip our clinicians with needed measurements of patient reported data giving us better insight into behaviors which helps us tailor our treatment plans even more to meet individual needs. We believe that these efforts will help to increase compliance and create efficiencies in how our treatment teams deliver care both now and in the future,” said Priest.
In 2022 Spero Health earned a Net Promoter Score (NPS) of 82.7 among patients in their outpatient addiction treatment program. This was the second year the organization earned a high score which is considered “world class” based on global NPS standards. Spero Health was also named “Top Workplace” in 2022 for the third year in a row.
About Spero Health
Spero Health, Inc., is an integrated healthcare services organization specializing in local and affordable outpatient care for individuals suffering from substance use disorders with a mission to “Save Lives, Instill Hope, and Restore Relationships.” Spero Health utilizes an innovative evidence-based integrated care model that combines both physical and behavioral healthcare services under one roof to treat the whole patient. This integrated care model combines physician services (including medication-assisted treatment), behavioral health counseling, recovery support services, medication management, and patient and family education. Its community-based approach to treatment allows patients to continue working and caring for their families as they overcome addiction.
Based in Nashville, Tenn. and privately held by Heritage Group, Health Velocity Capital, South Central, Inc. and Frist Cressey Ventures, Spero Health operates over 95 outpatient clinics located throughout Kentucky, Ohio, Indiana, Virginia, Tennessee, and West Virginia. Spero Health is a national leader who has helped more than 35,000 patients on their journey to stable recovery from addiction and is in-network with Medicaid and most commercial insurance plans.
For more information about Spero Health, please visit www.sperohealth.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20230105005730/en/
CONTACT: Ginger Jackson
KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE
INDUSTRY KEYWORD: MENTAL HEALTH HEALTH HOSPITALS OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL
SOURCE: Spero Health
Copyright Business Wire 2023.
PUB: 01/05/2023 10:10 AM/DISC: 01/05/2023 10:09 AM